Article
Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.
Journal of Clinical Oncology
(2013)
Disciplines
Publication Date
January 2, 2013
DOI
10.1200/jco.2013.31.4_suppl.310
Citation Information
Alex Cruz, Dung-Tsa Chen, William J. Fulp, Michael Chuong, et al.. "Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy." Journal of Clinical Oncology Vol. 31 (2013) p. 310 - 310 Available at: http://works.bepress.com/michael-chuong/14/